STING1 and neoplasm: Importantly, the combination of 6b and anti–PD-1 markedly inhibited WT-B16 tumor growth, but not STING-depleted tumors (Figure 13, A–C), indicating that 6b’s antitumor effect depends on SPOP/STING signaling.